Other Clinical Trial - Blood Draw Study for Liver Transplant Patients

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

Clinical Trial Description

The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Liver Transplant Recipients

Clinical Trial Details

NCT number	NCT01525797
Study type	Observational
Source	Baylor Research Institute
Contact
Status	Active, not recruiting
Phase	N/A
Start date	October 2002
Completion date	November 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00587418` - L-arginine for Prevention of Kidney Damage in Liver Transplant Recipients	N/A
Completed	`NCT01889758` - Pharmacokinetic Studies of Tacrolimus in Transplant Patients	Phase 4
Completed	`NCT02482974` - Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients	N/A
Completed	`NCT02320422` - Adult Liver Transplant Enhanced Care	N/A
Active, not recruiting	`NCT05077254` - COVID Protection After Transplant-Immunosuppression Reduction	Phase 2
Completed	`NCT00275639` - The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant	Phase 4
Completed	`NCT01672164` - Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients	N/A
Completed	`NCT01638559` - Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients	Phase 2
Recruiting	`NCT06418893` - Effect of TCI Propofol on Liver Transplant (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients.	Phase 2/Phase 3